Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur B Straughn

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 6, 2016
Absorption Differences between Immediate-Release Dexmethylphenidate and dl-MethylphenidateKennerly S Patrick, Arthur B Straughn
Pharmacotherapy|November 5, 2003
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulationsJohn S Markowitz, Arthur B Straughn, Kennerly S Patrick
Expert Opinion on Drug Delivery|November 22, 2005
New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorderKennerly S Patrick, Mario A González, Arthur B Straughn, et al.
Human Psychopharmacology|December 4, 2008
Evolution of stimulants to treat ADHD: transdermal methylphenidateKennerly S Patrick, Arthur B Straughn, Jeb S Perkins, et al.
Journal of Clinical Psychopharmacology|June 16, 2015
Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus MethylphenidateKennerly S Patrick, Arthur B Straughn, Owen T Reeves, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2008
A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oilPasut Ratanabanangkoon, Hector Guzman, Orn Almarsson, et al.
Pharmacotherapy|October 24, 2018
Drug Regimen Individualization for Attention-Deficit/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate FormulationsKennerly Sexton Patrick, Jennifer L Radke, John R Raymond, et al.
Clinical Pharmacokinetics|March 22, 2003
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adultsJohn S Markowitz, Arthur B Straughn, Kennerly S Patrick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2012
Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humansKennerly S Patrick, Arthur B Straughn, Owen T Reeves, et al.
Journal of Clinical Psychopharmacology|June 8, 2017
Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy VolunteersHao-Jie Zhu, Kennerly S Patrick, Arthur B Straughn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 6, 2016
Absorption Differences between Immediate-Release Dexmethylphenidate and dl-MethylphenidateKennerly S Patrick, Arthur B Straughn
Pharmacotherapy|November 5, 2003
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulationsJohn S Markowitz, Arthur B Straughn, Kennerly S Patrick
Expert Opinion on Drug Delivery|November 22, 2005
New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorderKennerly S Patrick, Mario A González, Arthur B Straughn, et al.
Human Psychopharmacology|December 4, 2008
Evolution of stimulants to treat ADHD: transdermal methylphenidateKennerly S Patrick, Arthur B Straughn, Jeb S Perkins, et al.
Journal of Clinical Psychopharmacology|June 16, 2015
Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus MethylphenidateKennerly S Patrick, Arthur B Straughn, Owen T Reeves, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2008
A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oilPasut Ratanabanangkoon, Hector Guzman, Orn Almarsson, et al.
Pharmacotherapy|October 24, 2018
Drug Regimen Individualization for Attention-Deficit/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate FormulationsKennerly Sexton Patrick, Jennifer L Radke, John R Raymond, et al.
Clinical Pharmacokinetics|March 22, 2003
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adultsJohn S Markowitz, Arthur B Straughn, Kennerly S Patrick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2012
Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humansKennerly S Patrick, Arthur B Straughn, Owen T Reeves, et al.
Journal of Clinical Psychopharmacology|June 8, 2017
Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy VolunteersHao-Jie Zhu, Kennerly S Patrick, Arthur B Straughn, et al.
Pageof 2